Immunoregulatory Therapy for 2019-nCoV (Q87076423)

From Wikidata

Jump to navigation Jump to search

clinical trial

edit

Language	Label	Description	Also known as
English	Immunoregulatory Therapy for 2019-nCoV	clinical trial

Statements

instance of

clinical trial

0 references

title

Immunoregulatory Therapy for 2019-nCoV-induced Severe Pneumonia Patients (English)

0 references

main subject

COVID-19

0 references

respiratory failure

0 references

start time

10 February 2020

0 references

end time

30 April 2020

0 references

number of participants

120

0 references

research intervention

immunoglobulin

0 references

clinical trial phase

phase II clinical trial

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT04268537

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87076423&oldid=2235306058"